Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoansLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colony Bankcorp (CBAN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Colony Bankcorp (CBAN) over the last 16 years, with Q3 2025 value amounting to $200.0 million.

  • Colony Bankcorp's Cash & Equivalents rose 3804.75% to $200.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $200.0 million, marking a year-over-year increase of 3804.75%. This contributed to the annual value of $231.0 million for FY2024, which is 17727.85% up from last year.
  • Colony Bankcorp's Cash & Equivalents amounted to $200.0 million in Q3 2025, which was up 3804.75% from $112.1 million recorded in Q2 2025.
  • Over the past 5 years, Colony Bankcorp's Cash & Equivalents peaked at $231.0 million during Q4 2024, and registered a low of $76.5 million during Q2 2022.
  • Over the past 5 years, Colony Bankcorp's median Cash & Equivalents value was $144.9 million (recorded in 2024), while the average stood at $139.4 million.
  • Per our database at Business Quant, Colony Bankcorp's Cash & Equivalents tumbled by 5909.49% in 2022 and then skyrocketed by 17727.85% in 2024.
  • Quarter analysis of 5 years shows Colony Bankcorp's Cash & Equivalents stood at $197.2 million in 2021, then crashed by 59.09% to $80.7 million in 2022, then increased by 3.28% to $83.3 million in 2023, then skyrocketed by 177.28% to $231.0 million in 2024, then dropped by 13.45% to $200.0 million in 2025.
  • Its Cash & Equivalents was $200.0 million in Q3 2025, compared to $112.1 million in Q2 2025 and $221.2 million in Q1 2025.